Advisory Council on Blood Stem Cell Transplantation, 62097 [2023-19398]
Download as PDF
<![CDATA[
Federal Register / Vol. 88, No. 173 / Friday, September 8, 2023 / Notices
approximately 1 week after the public
meeting.
FDA has verified the website
addresses in this document, as of the
date this document publishes in the
Federal Register, but websites are
subject to change over time.
Transcripts: Please be advised that as
soon as a transcript of the public
meeting is available, it will be accessible
at https://www.regulations.gov. A link to
the transcript will also be available at
https://www.fda.gov/about-fda/officeimmunology-and-inflammationdivision-rheumatology-and-transplantmedicine-drtm.
Dated: September 1, 2023.
Lauren K. Roth,
Associate Commissioner for Policy.
[FR Doc. 2023–19405 Filed 9–7–23; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
Advisory Council on Blood Stem Cell
Transplantation
Health Resources and Services
Administration (HRSA), Department of
Health and Human Services.
ACTION: Notice.
AGENCY:
In accordance with the
Federal Advisory Committee Act, this
notice announces that the Secretary’s
Advisory Council on Blood Stem Cell
Transplantation (ACBSCT or Advisory
Council) has scheduled public meetings.
Information about the Advisory Council
and the agenda for these meetings can
be found on the ACBSCT website at:
https://bloodstemcell.hrsa.gov/about/
advisory-council.
DATES: Thursday, September 28, 2023,
2:00 p.m.–6:00 p.m. Eastern Standard
Time; and Thursday, October 26, 2023,
2:00 p.m.–6:00 p.m. Eastern Standard
Time.
SUMMARY:
Both meetings will be held
virtually by webinar. A link to register
and join each meeting will be posted at
least 10 days prior to the meeting date
at: https://bloodstemcell.hrsa.gov/
about/advisory-council.
FOR FURTHER INFORMATION CONTACT:
Shelley Tims Grant, Designated Federal
Official, at the HRSA Health Systems
Bureau, Division of Transplantation,
5600 Fishers Lane, 8W–67, Rockville,
MD 20857; 301–443–8036; or
ACBSCTHRSA@hrsa.gov.
SUPPLEMENTARY INFORMATION: The
Advisory Council provides advice and
lotter on DSK11XQN23PROD with NOTICES1
ADDRESSES:
VerDate Sep<11>2014
17:30 Sep 07, 2023
Jkt 259001
recommendations to the Secretary of
Health and Human Services on policy,
program development, and other
matters of significance concerning the
activities under the authority of 42
U.S.C. 274k (section 379 of the Public
Health Service Act), as amended, and
Public Law 109–129, as amended. The
Advisory Council may transmit its
recommendations through the
Administrator of HRSA on matters
related to the activities of the C.W. Bill
Young Cell Transplantation Program
and National Cord Blood Inventory.
The agenda for the September 28,
2023, meeting is being finalized and
may include the following topics: the
Department of Health and Human
Services’ periodic review of the state of
the science of using adult stem cells and
birthing tissues to develop new types of
therapies for patients, for the purpose of
considering potential inclusion of such
new therapies in the C.W. Bill Young
Cell Transplantation Program; criteria
for defining a high-quality cord blood
unit for banking specifications; the
unmet needs in blood stem cell
transplantation and cellular therapy;
strategies to improve rates of donation
for adult blood stem cell donors; and
other areas to increase blood stem cell
donation and transplantation. The
agenda for the October 26, 2023,
meeting will be determined based on
discussion, priorities, and/or action
items from the September 28, 2023
meeting. All agenda items will be
posted on the Advisory Council’s
website no later than 10 days prior to
the respective meeting dates. Agenda
items are subject to change as priorities
dictate. Refer to the Advisory Council’s
website for any updated information
concerning the meeting. Members of the
public will have the opportunity to
provide comments. Public participants
may submit written statements in
advance of the scheduled meetings; oral
comments will be honored in the order
they are requested and may be limited
as time allows. Requests to submit a
written statement or make oral
comments to the Advisory Council
should be sent to Shelley Tims Grant,
using the contact information above at
least 3 business days prior to the
meeting. Individuals who plan to attend
and need special assistance or other
reasonable accommodations should
notify the Advisory Council at the
address and phone number listed above
at least 10 business days prior to the
meeting.
Maria G. Button,
Director, Executive Secretariat.
[FR Doc. 2023–19398 Filed 9–7–23; 8:45 am]
BILLING CODE 4165–15–P
PO 00000
Frm 00052
Fmt 4703
Sfmt 4703
62097
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Drug Abuse;
Amended Notice of Meeting
Notice is hereby given of a change in
the meeting of the National Advisory
Council on Drug Abuse, September 12,
2023, 10:30 a.m. to September 12, 2023,
05:00 p.m., National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852 which
was published in the Federal Register
on August 21, 2023, FR Doc 2023–
17889, 88 FR 56847.
This notice is being amended to
change the open session start time from
12:45 p.m. to 1:00 p.m. The open
session will now be held from 1:00 p.m.
to 5:00 p.m. on September 12, 2023. The
meeting is partially closed to the public.
Dated: September 1, 2023.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2023–19406 Filed 9–7–23; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
Notice of Meeting for the
Interdepartmental Serious Mental
Illness Coordinating Committee
(ISMICC)
Substance Abuse and Mental
Health Services Administration,
Department of Health and Human
Services.
ACTION: Notice.
AGENCY:
The Secretary of Health and
Human Services announces a meeting of
the Interdepartmental Serious Mental
Illness Coordinating Committee
(ISMICC).
The meeting will provide information
on federal efforts related to serious
mental illness (SMI) and serious
emotional disturbance (SED).
DATES: October 18, 2023, 10:00 a.m. to
4:00 p.m. (EDT)/Open.
ADDRESSES: The meeting is open to the
public and can be accessed virtually
only by accessing: https://
www.zoomgov.com/j/1608742409?
pwd=NjdoRlpGU2NoOH
paTzZVWXR3N0k4UT09, or by dialing
646–828–7666, webinar ID: 160 874
2409, passcode: 446018. Agenda with
call-in information will be posted on the
SUMMARY:
E:\FR\FM\08SEN1.SGM
08SEN1
]]>Agencies
[Federal Register Volume 88, Number 173 (Friday, September 8, 2023)]
[Notices]
[Page 62097]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-19398]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Resources and Services Administration
Advisory Council on Blood Stem Cell Transplantation
AGENCY: Health Resources and Services Administration (HRSA), Department
of Health and Human Services.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: In accordance with the Federal Advisory Committee Act, this
notice announces that the Secretary's Advisory Council on Blood Stem
Cell Transplantation (ACBSCT or Advisory Council) has scheduled public
meetings. Information about the Advisory Council and the agenda for
these meetings can be found on the ACBSCT website at: https://bloodstemcell.hrsa.gov/about/advisory-council.
DATES: Thursday, September 28, 2023, 2:00 p.m.-6:00 p.m. Eastern
Standard Time; and Thursday, October 26, 2023, 2:00 p.m.-6:00 p.m.
Eastern Standard Time.
ADDRESSES: Both meetings will be held virtually by webinar. A link to
register and join each meeting will be posted at least 10 days prior to
the meeting date at: https://bloodstemcell.hrsa.gov/about/advisory-council.
FOR FURTHER INFORMATION CONTACT: Shelley Tims Grant, Designated Federal
Official, at the HRSA Health Systems Bureau, Division of
Transplantation, 5600 Fishers Lane, 8W-67, Rockville, MD 20857; 301-
443-8036; or [email protected].
SUPPLEMENTARY INFORMATION: The Advisory Council provides advice and
recommendations to the Secretary of Health and Human Services on
policy, program development, and other matters of significance
concerning the activities under the authority of 42 U.S.C. 274k
(section 379 of the Public Health Service Act), as amended, and Public
Law 109-129, as amended. The Advisory Council may transmit its
recommendations through the Administrator of HRSA on matters related to
the activities of the C.W. Bill Young Cell Transplantation Program and
National Cord Blood Inventory.
The agenda for the September 28, 2023, meeting is being finalized
and may include the following topics: the Department of Health and
Human Services' periodic review of the state of the science of using
adult stem cells and birthing tissues to develop new types of therapies
for patients, for the purpose of considering potential inclusion of
such new therapies in the C.W. Bill Young Cell Transplantation Program;
criteria for defining a high-quality cord blood unit for banking
specifications; the unmet needs in blood stem cell transplantation and
cellular therapy; strategies to improve rates of donation for adult
blood stem cell donors; and other areas to increase blood stem cell
donation and transplantation. The agenda for the October 26, 2023,
meeting will be determined based on discussion, priorities, and/or
action items from the September 28, 2023 meeting. All agenda items will
be posted on the Advisory Council's website no later than 10 days prior
to the respective meeting dates. Agenda items are subject to change as
priorities dictate. Refer to the Advisory Council's website for any
updated information concerning the meeting. Members of the public will
have the opportunity to provide comments. Public participants may
submit written statements in advance of the scheduled meetings; oral
comments will be honored in the order they are requested and may be
limited as time allows. Requests to submit a written statement or make
oral comments to the Advisory Council should be sent to Shelley Tims
Grant, using the contact information above at least 3 business days
prior to the meeting. Individuals who plan to attend and need special
assistance or other reasonable accommodations should notify the
Advisory Council at the address and phone number listed above at least
10 business days prior to the meeting.
Maria G. Button,
Director, Executive Secretariat.
[FR Doc. 2023-19398 Filed 9-7-23; 8:45 am]
BILLING CODE 4165-15-P
